Please select the eligibility criteria that correspond to the clinical trial below.
Title: A PROMs Based Educational Tool (PROM-DA) for Patients Considering Total Knee Arthroplasty: Development and a Pilot Randomized Controlled Trial.
Brief Summary: The primary objectives of this study are to: 1) develop an educational tool known as the Patient Reported Outcome Measure informed Decision Aid (PROM-DA) that will describe the options for patients considering total knee arthroplasty (TKA) surgery, and help them imagine what to expect if they choose either option; 2) assess the extent that the PROM-DA improves patients decision quality; 3) determine the feasibility of a larger trial to test the PROM-DA in multiple sites and more patients.


Options:
A: Inclusion Criteria:

* Eligible individuals will be 13-18 years old who have an appointment to see a provider at a participating clinic and will be able to read and comprehend English.

Exclusion Criteria:

* Individuals will be excluded from the study if:

  * they do not meet age requirements,
  * do not have an appointment at a participating clinic,
  * lack the means to complete follow-up interviews (i.e., has neither telephone not internet access),
  * have a sibling who has/is being enrolled in the study and/or
  * are not able to read or comprehend English.
B: Inclusion Criteria:

* Adult (age≥30) patients with knee osteoarthritis (OA)
* Have an appointment with a surgeon for consultation about Total Knee Arthroplasty at the Edmonton Bone and Joint Centre
* Understands, speaks and reads English; and
* Able to provide informed consent.

Exclusion Criteria:

* Individuals who have had prior total knee arthroplasty
* Physician-diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, or Gout.
C: Inclusion Criteria:

* Adult over 18 years.
* Patient with Rheumatoid Arthritis diagnosed according to American College of Rheumatology (ACR ) / European League Against Rheumatism (EULAR) 2010 criteria.
* Patient monitored by the recruiting physician from over a year.
* Patient access who have access to an Internet broadband equipment other than on a mobile or a a smartphone

Exclusion Criteria:

* Patient already using Sanoia at the time of inclusion.
* Patient already participating in a therapeutic clinical trial in rheumatology
* Patient having no computer literacy and understanding difficulties
D: Inclusion Criteria:

* primary colorectal cancer
* operated in one of four participating certified cancer centres for colorectal cancer (Krankenhaus Barmherzige Brüder, Department of Surgery, Regensburg; Germany; Caritas-Krankenhaus St. Josef, Department of Surgery, Regensburg; Germany; Klinikum Neumarkt., Department of Surgery, Neumarkt; Germany; Klinikum St. Elisabeth Straubing, Department of Surgery, Straubing, Germany), documented in a population-based cancer registry (Tumor Center Regensburg e.V.)
* informed consent.

Exclusion Criteria:

* coordinating practitioner not implemented
* patient from district outside the study region (rural districts Regensburg, Neumarkt, Straubing, Straubing-Bogen, Kelheim, Schwandorf)
* patient unable to fill out the questionnaire for physical, psychological or language reasons (including dementia)
* age under 18 years
* pregnancy
* QoL clinician unavailable
* refusal to participate

Answer: B